Manhattan myriad myrisk genetic testing providers at Gramercy Park offer a genetic test that identifies inherited cancer risk by analyzing multiple genes to assess an individual’s predisposition to developing certain cancers in the New York–Newark–Bridgeport area.

Receiving your MyRisk results is empowering. Whether your genetic risk is elevated or not, you gain clarity about your personal cancer risk profile. If a hereditary risk is found, you can proactively pursue targeted screening, lifestyle adjustments, or preventive measures with the guidance of your healthcare provider. If no significant mutations are detected, you can move forward with peace of mind. Either way, the knowledge equips you with the ability to make smarter, life-affirming decisions for yourself and your loved ones. Myriad MyRisk Genetic Testing is a groundbreaking scientific advancement that helps uncover inherited cancer risks, offering life-changing, proactive insights to protect your health and the health of your family. Nonkulie Dladla, M.D. offers personalized genetic cancer risk testing in the New York–Newark–Bridgeport, New York area.

Myriad MyRisk Genetic Testing examines dozens of genes known to influence hereditary cancer syndromes, including BRCA1, BRCA2, Lynch syndrome genes, and others. Using a simple blood or saliva sample, the test employs advanced sequencing technology to detect genetic mutations linked to increased cancer risk. Unlike basic single-gene tests, MyRisk provides a comprehensive risk analysis across multiple cancers such as breast, ovarian, colorectal, prostate, and more. The results include a personalized medical management plan, empowering both patients and physicians with specific, actionable next steps. By integrating genetic insights with clinical guidelines, MyRisk stands as a superior tool for cancer risk assessment and prevention. Manhattan optimal health and wellness specialists at Gramercy Park Regenerative Medicine treat family history of cancer, personal history of cancer, multiple primary cancers, rare cancers, early-onset cancer, and hereditary cancer patterns using MyRisk in New York and surrounding New York County areas.

Do you know if your family history of cancer could put you at greater risk, and would you want to find out before it’s too late? Call (917) 764-3051 to schedule your Myriad MyRisk Genetic Testing consultation today!

Benefits of Myriad MyRisk Genetic Testing

Nonkulie Dladla, M.D. helps New York–Newark–Bridgeport patients achieve optimal health by delivering superior care through innovative medicine. Discover the benefits of Genetic Cancer Risk Testing offered by integrative health and wellness experts at Gramercy Park Regenerative & Integrative Medicine in New York, New York.

MyRisk reveals inherited genetic risks before cancer develops, giving you time to take preventive action.

Test results enable your healthcare team to recommend tailored screening and risk-reduction plans specific to your genetic profile.

Unlike traditional tests, MyRisk evaluates multiple cancer types, including breast, ovarian, prostate, pancreatic, and colorectal cancers.

Knowing your genetic risk helps family members assess their own health risks and take appropriate steps.

MyRisk analyzes a wide panel of genes with proven links to hereditary cancers, offering more thorough results than limited-scope tests.

Beyond genetic findings, MyRisk provides a management plan that helps you and your doctor make well-informed decisions about prevention and care.

A man lifts a woman up on the beach, framed by the sunset. Get Myrisk genetic cancer screening from Nonkulie Dladla, M.D. in Manhattan.

You deserve the power to make informed choices about your health. With MyRisk Genetic Testing, you can take control of your future with confidence.

Call Nonkulie Dladla, M.D. at (917) 764-3051 to schedule a Genetic Cancer Risk Testing consultation!